donanemab Archives - TPR: The Public's Radio

A survey of older Americans found that 79% would want to know if they were in the early stages of Alzheimer’s, and 92% said that if diagnosed, they would probably or definitely want to take a drug that could slow down the disease’s progression. The results may indicate a recent shift in openness toward Alzheimer's testing and treatment.

NPR

More and more older Americans want to know their Alzheimer’s status, survey finds

by Jon Hamilton April 30, 2025April 30, 2025

A survey of 1700 Americans 45 and older found that 79% would want to know if they were in the early stages of Alzheimer’s.

NPR

FDA advisors strongly back new Alzheimer’s drug, despite risks and limitations

by Jon Hamilton June 10, 2024July 9, 2024

Advisors to the Food and Drug Administration have recommended unanimously that the agency approve the Alzheimer’s drug donanemab.

{{ index + 1 }}
{{ track.track_title }} {{ track.track_artist }} {{ track.album_title }} {{ track.length }}

{{list.tracks[currentTrack].track_title}}{{list.tracks[currentTrack].track_artist && typeof sonaar_music.option.show_artist_name != 'undefined' ? ' ' + sonaar_music.option.artist_separator + ' ' + list.tracks[currentTrack].track_artist:''}}

{{classes.speedRate}}X